Back to search
Meniscal Degeneration
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Meniscal Degeneration trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Meniscal Degeneration trials you may qualify forThe value of corticosteroid infiltration of the meniscus wall in the therapeutic strategy is not clearly defined: the data in the literature on the effectivenes…
Knee pain due to a degenerative meniscal tear (DMT) or early osteoarthritis (OA) is a frequent presentation in middle-aged and older adults. In the knee joint a…
The main hypothesis of the study is that in situ infiltration of the meniscal lesion would provide patients with lasting and greater relief than intra-articular…
Knee osteoarthritis is a disabling problem affecting over 15 million adults in the United States. Many people who have knee arthritis also experience painful me…
Meniscal tissue has very limited intrinsic properties in terms of repair, given the low mitotic activity of chondrocytes and poor vascularization. Nevertheless,…